Roche’s Virtual Early Drug Development gRED Event 2020
Agenda
Welcome
Overview and Introduction to Genentech (gRED)
Oncology Pipeline Overview
Cancer Immunotherapy
Q&A
Karl Mahler, Head of Investor Relations and Roche Group Planning
Michael Varney, Head of Genentech Research and Early Development
Stuart Lutzker, Vice President, Oncology Research and ad interim Head of Early Clinical Development for gRED
Ira Mellman, Vice President, Cancer Immunology and Immunology for gRED

Please register to access the replay*

*Privacy notice

Live Webinar Replay

Roche has hosted a live video webcast on Tuesday, 18 February 2020.

Investors
Past IR Events
View more Events

Downloads

Related links